BNTX - BioNTech SE - ADR
IEX Last Trade
88.25
0.650 0.737%
Share volume: 595,074
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$87.60
0.65
0.74%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-07 | 2023-03-27 | 2023-05-08 | 2023-08-07 | 2023-11-06 | 2024-03-20 | 2024-05-06 | |
| Total revenue | 3.341 B | 3.392 B | 4.721 B | 1.392 B | 182.304 M | 947.257 M | 1.700 B | 202.610 M | |
| Cost of revenue | 799.271 M | 737.704 M | 231.332 M | 104.672 M | 177.086 M | 171.190 M | 210.162 M | 63.829 M | |
| Gross profit | 2.542 B | 2.654 B | 4.489 B | 1.288 B | 5.218 M | 776.067 M | 1.490 B | 138.781 M | |
| 4.40% | 69.15% | -71.32% | -99.59% | 14,772.91% | 92.00% | -90.69% | |||
| Operating expenses | 572.222 M | 485.661 M | 738.251 M | 507.659 M | 558.977 M | 694.916 M | 826.319 M | 691.315 M | |
| Selling general and admin | 154.502 M | 150.716 M | 161.221 M | 143.488 M | 153.061 M | 168.121 M | 151.895 M | 143.209 M | |
| Research and development | 417.720 M | 334.946 M | 577.030 M | 364.171 M | 405.916 M | 526.795 M | 674.424 M | 548.105 M | |
| Total expenses | 1.623 B | 1.503 B | 795.245 M | 612.331 M | 736.063 M | 866.106 M | 1.049 B | 755.143 M | |
| -7.42% | -47.08% | -23.00% | 20.21% | 17.67% | 21.15% | -28.03% | |||
| Operating income | 1.718 B | 1.889 B | 3.925 B | 780.024 M | -553.759 M | 81.151 M | 650.875 M | -552.533 M | |
| Ebit | 2.310 B | 2.340 B | 2.733 B | 780.024 M | -553.759 M | 81.151 M | 650.875 M | -552.533 M | |
| Pretax income | 2.424 B | 2.395 B | 3.475 B | 771.629 M | -448.095 M | 240.597 M | 747.163 M | -358.347 M | |
| -1.21% | 45.10% | -77.80% | -158.07% | -153.69% | 210.55% | -147.96% | |||
| Income tax | 676.652 M | 645.981 M | 980.368 M | 224.063 M | -241.115 M | 70.677 M | 229.174 M | -18.036 M | |
| Net income basic | 1.748 B | 1.749 B | 2.495 B | 547.565 M | -206.980 M | 169.920 M | 517.988 M | -340.311 M | |
| 0.07% | 42.64% | -78.05% | -137.80% | 182.09% | 204.84% | -165.70% | |||
| Net income | 1.748 B | 1.749 B | 2.495 B | 547.565 M | -206.980 M | 169.920 M | 517.988 M | -340.311 M | |
| 0.07% | 42.64% | -78.05% | -137.80% | 182.09% | 204.84% | -165.70% |